Cohen Capital Management Inc. Acquires 3,897 Shares of Zoetis Inc. $ZTS

Cohen Capital Management Inc. raised its holdings in Zoetis Inc. (NYSE:ZTS) by 30.3% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 16,749 shares of the company’s stock after acquiring an additional 3,897 shares during the period. Cohen Capital Management Inc.’s holdings in Zoetis were worth $2,451,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Scott & Selber Inc. raised its stake in Zoetis by 0.6% in the second quarter. Scott & Selber Inc. now owns 11,652 shares of the company’s stock valued at $1,817,000 after purchasing an additional 67 shares in the last quarter. North Star Asset Management Inc. increased its holdings in shares of Zoetis by 4.9% in the 2nd quarter. North Star Asset Management Inc. now owns 1,441 shares of the company’s stock worth $225,000 after buying an additional 67 shares during the last quarter. Secure Asset Management LLC raised its position in shares of Zoetis by 2.9% during the 2nd quarter. Secure Asset Management LLC now owns 2,448 shares of the company’s stock valued at $382,000 after buying an additional 68 shares in the last quarter. Moment Partners LLC raised its position in shares of Zoetis by 3.2% during the 2nd quarter. Moment Partners LLC now owns 2,354 shares of the company’s stock valued at $367,000 after buying an additional 72 shares in the last quarter. Finally, CVA Family Office LLC lifted its holdings in shares of Zoetis by 6.7% during the 2nd quarter. CVA Family Office LLC now owns 1,173 shares of the company’s stock worth $183,000 after acquiring an additional 74 shares during the last quarter. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on ZTS. JPMorgan Chase & Co. reduced their target price on Zoetis from $230.00 to $200.00 and set an “overweight” rating on the stock in a research note on Wednesday, November 5th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Zoetis in a report on Monday, December 29th. HSBC set a $140.00 price objective on Zoetis in a report on Wednesday, December 10th. BTIG Research reaffirmed a “buy” rating and issued a $160.00 target price on shares of Zoetis in a research note on Wednesday, December 3rd. Finally, Stifel Nicolaus decreased their price target on shares of Zoetis from $140.00 to $130.00 and set a “hold” rating on the stock in a research note on Tuesday, November 18th. Six equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $160.18.

Zoetis Stock Performance

Shares of ZTS stock opened at $129.41 on Tuesday. The company has a market capitalization of $57.03 billion, a P/E ratio of 21.79, a PEG ratio of 2.57 and a beta of 0.97. Zoetis Inc. has a fifty-two week low of $115.25 and a fifty-two week high of $177.40. The company has a debt-to-equity ratio of 1.31, a quick ratio of 2.28 and a current ratio of 3.64. The stock has a 50 day moving average price of $124.66 and a two-hundred day moving average price of $141.33.

Zoetis (NYSE:ZTS) last issued its earnings results on Tuesday, November 4th. The company reported $1.70 EPS for the quarter, topping the consensus estimate of $1.62 by $0.08. Zoetis had a net margin of 28.21% and a return on equity of 57.19%. The company had revenue of $2.40 billion for the quarter, compared to the consensus estimate of $2.42 billion. The firm’s revenue for the quarter was up .5% on a year-over-year basis. During the same period in the previous year, the firm earned $1.58 earnings per share. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Analysts expect that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 3rd. Stockholders of record on Tuesday, January 20th will be issued a dividend of $0.53 per share. This is an increase from Zoetis’s previous quarterly dividend of $0.50. This represents a $2.12 dividend on an annualized basis and a dividend yield of 1.6%. The ex-dividend date is Tuesday, January 20th. Zoetis’s dividend payout ratio (DPR) is currently 35.69%.

About Zoetis

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.